Opioid ‘kingpin’ J&J fueled epidemic, Oklahoma argues at trial’s end
NORMAN, Okla. (Reuters) – Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson (JNJ.N) to a drug cartel leader as they sought to hold the drugmaker responsible…
by October Gallery
NORMAN, Okla. (Reuters) – Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson (JNJ.N) to a drug cartel leader as they sought to hold the drugmaker responsible…
(Reuters) – An Oklahoma judge on Monday approved a revised $85 million (£66.7 million) settlement with Teva Pharmaceutical Industries Ltd resolving claims by the state’s attorney general that the drugmaker…
(Reuters) – An Oklahoma judge on Monday approved a revised $85 million (£66.7 million) settlement with Teva Pharmaceutical Industries Ltd resolving claims by the state’s attorney general that the drugmaker…
(Reuters) – Lawyers for counties and municipalities suing drug manufacturers and distributors over their alleged roles in the U.S. opioid epidemic on Friday pitched a novel plan that would bring…
(Reuters Health) – More than three years after Pennsylvania issued a statewide order expanding access to the life-saving opioid antidote naloxone, the product was still hard to purchase in Philadelphia…
(Reuters) – Insys Therapeutics Inc agreed to pay $225 million and an operating unit agreed to plead guilty to five mail fraud counts to settle criminal and civil probes into…
Poor people with opioid use disorders may struggle to find doctors to prescribe the anti-addiction drug buprenorphine in U.S. states with the highest overdose death rates, a new study suggests.…
(Reuters) – The father of a college football player who died of a drug overdose gave emotional testimony about the U.S. opioid epidemic’s personal cost on Wednesday in the second…
(Reuters Health) – Dentists in the U.S. prescribe opioids at a rate 70 times higher than dentists in England, a new study finds. Moreover, the types of opioids prescribed by…
NORMAN, Okla. (Reuters) – Johnson & Johnson’s greed led the drugmaker to use deceptive marketing to create an oversupply of painkillers that fueled the U.S. opioid epidemic, the state of…